drugset / Trial / NCT00208559

Ziprasidone in Children With Autism: A Pilot Study

NCT00208559

Phase 2 Completed 15 enrolled Drexel University College of Medicine
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if the drug, ziprasidone, is effective in treating problems in adolescent associated with autism.

Timeline

Start
2002-02
Primary completion
2005-06
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ziprasidone Small molecule 40 mg
Subject Ziprasidone Small molecule 60 mg

Indications